Lupin announced the launch of Silodosin Capsules 4mg and 8mg,
having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin's Silodosin Capsules 4mg and 8mg; is the generic equivalent of AIIergan's Rapaflo. An alpha-l adrenergic receptor antagonist, it is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).
Rapaflo had annual sales of $198.5 million in the US (IQVIA MAT September 2018).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
